We are live on
!
Find out more
ZDA
Zweig-DiMenna Associates Portfolio holdings
AUM
$722M
1-Year Est. Return
97.69%
This Fund
S&P 500
This Quarter
Est. Return
+9.69%
1 Year Est. Return
+97.69%
3 Year Est. Return
+317.96%
5 Year Est. Return
+499.45%
10 Year Est. Return
+3,067.75%
AUM
$2.19B
AUM Growth
+$496M
(+29%)
Cap. Flow
+$360M
Cap. Flow
% of AUM
16.44%
Top 10 Holdings %
Top 10 Hldgs %
25.33%
Holding
336
New
112
Increased
48
Reduced
55
Closed
93
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$47.8M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$47.4M |
| 3 |
SNDK
SANDISK CORP
SNDK
|
+$34.5M |
| 4 |
Elevance Health
ELV
|
+$32.9M |
| 5 |
Micron Technology
MU
|
+$30.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Host Hotels & Resorts
HST
|
+$40.9M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$28.3M |
| 3 |
Visa
V
|
+$21.3M |
| 4 |
Cemex
CX
|
+$20.7M |
| 5 |
Incyte
INCY
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.27% |
| 2 | Technology | 12.24% |
| 3 | Communication Services | 10.49% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Financials | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Royal Gold
RGLD
$17.1B
| $274K | 0.01% |
+3,600
| New | +$238K |
|
|
LVNTA
177
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $273K | 0.01% |
7,530
+204
| +3% | +$6.42K |
|
|
ADT
178
DELISTED
ADT Corp
ADT
| $273K | 0.01% |
+7,800
| New | +$250K |
|
|
WLL
179
DELISTED
Whiting Petroleum Corporation
WLL
| $273K | 0.01% |
11
-1
| -8% | -$22.2K |
|
180
Intel
INTC
$509B
| $272K | 0.01% |
+8,800
| New | +$241K |
|
181
Southwest Airlines
LUV
$23B
| $271K | 0.01% |
10,100
-200
| -2% | -$5.04K |
|
182
Pilgrim's Pride
PPC
$6.65B
| $271K | 0.01% |
+9,900
| New | +$235K |
|
183
Trinity Industries
TRN
$2.5B
| $271K | 0.01% |
+8,612
| New | +$244K |
|
184
Celanese
CE
$4.96B
| $270K | 0.01% |
+4,200
| New | +$255K |
|
|
ATVI
185
DELISTED
Activision Blizzard
ATVI
| $270K | 0.01% |
+12,100
| New | +$249K |
|
186
TransDigm Group
TDG
$71.3B
| $269K | 0.01% |
+1,610
| New | +$290K |
|
187
H&R Block
HRB
$5.73B
| $268K | 0.01% |
+8,000
| New | +$238K |
|
188
National Grid
NGG
$80.3B
| $268K | 0.01% |
+3,732
| New | +$258K |
|
189
Pultegroup
PHM
$24.6B
| $268K | 0.01% |
+13,300
| New | +$255K |
|
|
HES
190
DELISTED
Hess
HES
| $267K | 0.01% |
2,700
-400
| -13% | -$36.1K |
|
191
Pfizer
PFE
$145B
| $267K | 0.01% |
+9,486
| New | +$270K |
|
192
Molson Coors Class B
TAP
$7.86B
| $267K | 0.01% |
+3,600
| New | +$232K |
|
193
Intuit
INTU
$88.5B
| $266K | 0.01% |
3,300
+300
| +10% | +$23.1K |
|
194
Chord Energy
CHRD
$7.71B
| $263K | 0.01% |
+4,700
| New | +$227K |
|
|
BT
195
DELISTED
BT Group plc (ADR)
BT
| $263K | 0.01% |
8,000
+200
| +3% | +$6.43K |
|
196
British American Tobacco
BTI
$128B
| $262K | 0.01% |
+4,400
| New | +$258K |
|
|
QEP
197
DELISTED
QEP RESOURCES, INC.
QEP
| $262K | 0.01% |
+7,600
| New | +$240K |
|
|
C.WS.B
198
DELISTED
CITIGROUP INC WTS EXP (10/28/2018) (DE)
C.WS.B
| $260K | 0.01% |
8,666,740
| – | – |
|
199
Nu Skin
NUS
$259M
| $259K | 0.01% |
+3,500
| New | +$276K |
|
|
QCOR
200
DELISTED
QUESTCOR PHARMA INC
QCOR
| $259K | 0.01% |
+2,800
| New | +$240K |
|
Similar funds
FIS
ZAM
PPW
VCM
FFM
WLIM
AGAM
TFHU
Zweig-DiMenna Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Zweig-DiMenna Associates held 336 positions worth $2.19B, up 29% from $1.69B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Zweig-DiMenna Associates deployed $360M of net new capital in Q2 2014, opening 112 new positions and adding to 48 existing holdings. Its largest new stake was Allergan Inc: 306,708 shares worth $51.9M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 9.1% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Twenty-First Century Fox, Inc. Class A, an estimated $28.3M trimmed.
- Zweig-DiMenna Associates's largest Q2 2014 buy was Allergan Inc: 306,708 shares worth $51.9M.
- Zweig-DiMenna Associates added most to Micron Technology in Q2 2014, an estimated $30.7M increase.
- Zweig-DiMenna Associates's biggest Q2 2014 reduction was Twenty-First Century Fox, Inc. Class A, cutting an estimated $28.3M.
- Zweig-DiMenna Associates fully exited Host Hotels & Resorts in Q2 2014, selling an estimated $40.9M.
- Zweig-DiMenna Associates's ten largest holdings make up 25% of its $2.19B portfolio in Q2 2014.
- Zweig-DiMenna Associates opened 112 new positions and closed 93 in Q2 2014.
- Zweig-DiMenna Associates's portfolio value rose 29% quarter-over-quarter to $2.19B.
Based on Zweig-DiMenna Associates's 13F filing for Q2 2014, filed 12 Aug 2014.